Skip to content

Correlations of the Microvascular Abnormalities on NVC (Nail Fold Video Capillaroscopy) and GAVE (Gastric Antral Vascular Ectasia) as Seen on EGD

Correlations of the Microvascular Abnormalities on NVC (Nail Fold Video Capillaroscopy) and GAVE (Gastric Antral Vascular Ectasia) as Seen on EGD

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07127952
Acronym
GAVE
Enrollment
75
Registered
2025-08-17
Start date
2025-05-03
Completion date
2026-12-31
Last updated
2026-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Antral Vascular Ectasia

Keywords

GAVE, G.A.V.E, Gastric Antral Vascular, Gastric Antral Vascular Ectasia

Brief summary

The purpose of this research is to determine whether a procedure called capillaroscopy can help distinguish patients who are diagnosed with GAVE (gastric antral vascular ectasia) with an autoimmune disease versus idiopathic/other conditions based on EGD findings.

Detailed description

The primary aim of this study is to define the prevalence and findings (as per quantification) of nail fold video capillaroscopy abnormalities in patients with GAVE. The secondary aim is to compare the findings of NVC and clinical presentation in patients with GAVE.

Interventions

DEVICEVideo Capillaroscopy

A non-invasive imaging technique used to assess capillary structure and morphology in the nailfold area, commonly used in evaluating microvascular changes associated with connective tissue diseases.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Patients 18 years and older with gave diagnosis as pair EGD performed in Gastroenterology as standard of care. Patients with GAVE with connective tissue disease will be compared to patients with GAVE without a connective tissue disease.

Exclusion criteria

* Age less than 18 years of age, pregnant individuals, dialysis dependent, type 2 diabetes, recent hand trauma or manicure (\<2 weeks), routine use of vibratory tools, history of acrocyanosis or erythromelalgia, previous diagnosis of a bleeding disorder, diagnosis of psoriasis, diagnosis of anti-phospholipid syndrome, exposure to toluene or benzoyl, diagnosis of psoriasis, diagnosis of COPD.

Design outcomes

Primary

MeasureTime frameDescription
Prevalence and Phenotypic with G.A.V.EFrom enrollment to end of study once the accrual has been met within baseline of Day 1Defined the prevalence and phenotype of nail fold video capillaroscopy abnormalities in patients with G.A.V.E.

Secondary

MeasureTime frameDescription
Comparing FindingsFrom enrollment to end of study once the accrual has been met within baseline of day 1To compare the findings of and VC and clinical manifestation and organ involvement patients with gave and connective tissue disease to those with gave without connective tissue disease.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORFlorentina Berianu, M.D.

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026